HemoSonics Wins Best Medical Device Company in Triangle Business Journal's 2025 Life Sciences Awards
"Innovation is at the heart of what we do at HemoSonics, and we're thrilled to be mentioned alongside other Research Triangle Park companies who are changing the world for the better through medical and scientific advances."
Share
According to data from the North Carolina Biotechnology Center, North Carolina is home to 840 life sciences companies, with the lion's share based in the Triangle. The Triangle Business Journal's Life Sciences Awards recognize 12 individuals and research organizations from the Research Triangle, North Carolina (Raleigh, Durham and Chapel Hill region) that are leading and breaking ground in this field. The broad spectrum of the life sciences arena encompasses biotechnology, pharmaceuticals, clinical research, human health, medical devices and diagnostics, and other related fields.
The HemoSonics Quantra Hemostasis System consists of the Quantra Hemostasis Analyzer, along with QPlus and QStat Cartridges. The System provides fast, comprehensive whole-blood coagulation analysis at the point of care or in laboratory settings in under 15 minutes, empowering clinicians with information to inform patient-centered decisions that improve care and optimize blood product usage. The Quantra System uses innovative SEER Sonorheometry (Sonic Estimation of Elasticity via Resonance), a proprietary medical-grade ultrasound technology that measures the coagulation properties of a whole blood sample.
HemoSonics' Quantra System is FDA-cleared for cardiovascular surgery, trauma, liver transplantation, and major orthopedic surgery. It requires minimal resources to maintain, is easy to operate and interpret, and enables hospitals to standardize a clinically and operationally efficient viscoelastic testing program.
'The Research Triangle Park has long been recognized as a catalyst for pioneering technologies in biotechnology, medical devices, and health technology, and this community is one of the key reasons we chose Durham for our headquarters,' said Bob Roda, HemoSonics President and CEO. 'Innovation is at the heart of what we do at HemoSonics, and we're thrilled to be mentioned alongside companies who are changing the world for the better through medical and scientific advances.'
HemoSonics' Quantra Hemostasis System technology has received numerous accolades, including the 2024 TIME Best Inventions, 2024 Fast Company Most Innovative Companies (Medtech), 2024 Edison Awards (Point-of-Care and Therapeutic Solutions), and the 2024 Deloitte Fast 500, which recognizes the fastest-growing companies in North America.
About HemoSonics:
HemoSonics, LLC is a medical device technology company focused on acute bleeding management, resulting in better patient care and lower overall medical costs. The Quantra Hemostasis Analyzer, HemoSonics' flagship product, is designed to improve patient outcomes and reduce healthcare costs by providing optimized coagulation information. The Quantra System's easy and fast interpretation enables simple, more efficient point-of-care and laboratory bleeding management.
Based in Durham, North Carolina, HemoSonics is part of the Stago Group, a leading in vitro diagnostics company dedicated to exploring thrombosis and hemostasis. Visit HemoSonics.com to learn more.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
6 days ago
- Yahoo
HemoSonics Wins 2025 Supplier Horizon Award from Premier, Inc.
One of 13 companies to receive Premier, Inc.'s Supplier Horizon Award for excellence in improving healthcare performance, HemoSonics' Quantra Hemostasis System provides comprehensive hemostasis analysis in less than 15 minutes DURHAM, N.C., July 17, 2025--(BUSINESS WIRE)--HemoSonics LLC, a medical device company focused on acute bleeding management, today announced it has won the 2025 Supplier Horizon Award from Premier, Inc., a leading technology-driven healthcare performance improvement company. HemoSonics was honored for its Quantra Hemostasis System, an advanced viscoelastic testing device that accelerates decision-making, enhances patient outcomes and reduces healthcare costs by delivering rapid, actionable coagulation assessments in near real-time. One of 13 suppliers to receive the award this year, HemoSonics was recognized for its support of Premier members through exceptional local customer service and engagement, as well as value creation through clinical excellence and a commitment to lower costs. Supplier Horizon Award winners are selected by Premier member committees and have a tenure of less than three years as a Premier contracted supplier. HemoSonics' Quantra Hemostasis System comprises the Quantra Hemostasis Analyzer with QPlus and QStat Cartridges. The Quantra System utilizes innovative SEER Sonorheometry (Sonic Estimation of Elasticity via Resonance), a proprietary ultrasound technology that measures the coagulation properties of a whole blood sample, providing comprehensive coagulation analysis in under 15 minutes. Doctors receive test results quickly during critical and complex surgeries, enabling timely, patient-centered decisions about bleeding management, which improves care and optimizes the use of blood products. "Our mission is to ensure that our clinician partners receive accurate test results quickly during critical, complex surgeries that allow them to make timely patient-centered clinical decisions. By doing so, patients can receive the care that they need at the moment that they need it. We will continue to work tirelessly to ensure that our customers and partners are supported, as we partner with hospitals to deliver better patient outcomes, all while lowering the cost of care," said HemoSonics President and CEO Bob Roda. "We are humbled and proud to receive the Supplier Horizon Award from Premier, Inc." HemoSonics' Quantra System is FDA-cleared for use in cardiovascular and major orthopedic surgery, trauma, and liver transplantation. It requires minimal resources to maintain, is easy to operate and interpret results, and enables hospitals to standardize a clinically and operationally efficient viscoelastic testing program. According to a 2023 Journal of Cardiothoracic Surgery study, Quantra reduced blood component use between 10% and >90%. In addition, the cost of blood products decreased by 41%. "HemoSonics supports Premier members by offering products and services that help improve costs, quality and operations – and deliver overall value," said Bruce Radcliff, Senior Vice President of Supply Chain at Premier. "We're honored to recognize HemoSonics as a Supplier Horizon Award recipient." The Supplier Horizon Award recipients were honored during Premier's annual Breakthroughs Conference & Exhibition, July 15-17, 2025. About HemoSonics HemoSonics, LLC is a medical device technology company focused on acute bleeding management, resulting in better patient care and lower overall medical costs. The Quantra Hemostasis Analyzer, HemoSonics' flagship product, is designed to improve patient outcomes and reduce healthcare costs by providing optimized coagulation information. The Quantra System's ease of use and fast interpretation of results enable simple, more efficient point-of-care and laboratory bleeding management. Based in Durham, North Carolina, HemoSonics is part of the Stago Group, a leading in vitro diagnostics company dedicated to exploring thrombosis and hemostasis. Follow HemoSonics on LinkedIn or visit to learn more. View source version on Contacts Media Contacts: Mindy M. HullMercury Global Partners for HemoSonics+1 415 889 9977 (San Francisco)hemosonics@ Michael Held-HernandezMercury Global Partners for HemoSonics+1 480 306 1154 (Washington D.C.)hemosonics@
Business Journals
18-06-2025
- Business Journals
Micropep partners with Corteva to develop crop protections
2025 40 Under 40 Awards For the 25th year Triangle Business Journal will recognize 40 of the Triangle's best and brightest business and community leaders- all under the age of 40!
Business Journals
11-06-2025
- Business Journals
Durhamite Southcourt owners sign new tenants, start renovations
2025 40 Under 40 Awards For the 25th year Triangle Business Journal will recognize 40 of the Triangle's best and brightest business and community leaders- all under the age of 40!
